Anti-resorptive medication use is not associated with acute cardiovascular risk: An observational study: Anti-resorptive medication and cardiovascular risk.
Dana BliucThach S TranWeiwen ChenDunia AlarkawiDima A AlajlouniFiona BlythLyn MarchRobert Daniel BlankJacqueline R CenterPublished in: The Journal of clinical endocrinology and metabolism (2022)
oBP and Dmab use was not associated with CVE.